KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Interest Expenses (2016 - 2022)

Biolife Solutions (BLFS) has disclosed Interest Expenses for 12 consecutive years, with $7000.0 as the latest value for Q3 2021.

  • On a quarterly basis, Interest Expenses rose 133.33% to $7000.0 in Q3 2021 year-over-year; TTM through Jun 2022 was $7000.0, a 216.67% increase, with the full-year FY2019 number at $13000.0, up 160.0% from a year prior.
  • Interest Expenses was $7000.0 for Q3 2021 at Biolife Solutions, up from -$9000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $104582.0 in Q2 2017 to a low of -$9000.0 in Q4 2020.
  • A 5-year average of $15736.6 and a median of $2156.5 in 2018 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: surged 1155.03% in 2017, then plummeted 212.5% in 2020.
  • Biolife Solutions' Interest Expenses stood at $1008.0 in 2017, then fell by 0.79% to $1000.0 in 2018, then skyrocketed by 700.0% to $8000.0 in 2019, then tumbled by 212.5% to -$9000.0 in 2020, then skyrocketed by 177.78% to $7000.0 in 2021.
  • Per Business Quant, the three most recent readings for BLFS's Interest Expenses are $7000.0 (Q3 2021), -$9000.0 (Q4 2020), and $3000.0 (Q3 2020).